Literature DB >> 1932306

Nonsecretion of myeloma protein in spite of an increase in tumor burden by chemotherapy.

K Kubota1, H Kurabayashi, E Kawada, K Okamoto, J Tamura, T Shirakura.   

Abstract

A unique case of IgA kappa myeloma is presented. While the myeloma cells had secreted a large quantity of IgA kappa monoclonal protein, they were induced to stop secreting the monoclonal protein by cyclophosphamide and vincristine, in spite of a remarkable increase in tumor burden. The absence of intracytoplasmic IgA kappa was clearly evidenced by the immunofluorescence technique using anti-IgA and anti-kappa monoclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1932306     DOI: 10.1007/bf01703451

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  5 in total

1.  [Contribution to the problem of plasmacytoma without paraproteins].

Authors:  F Michot
Journal:  Dtsch Med Wochenschr       Date:  1968-10-25       Impact factor: 0.628

2.  Decreasing M spike with increasing tumor burden in multiple myeloma.

Authors:  D M Sahasrabudhe; J C Parker
Journal:  Arch Intern Med       Date:  1981-08

3.  A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.

Authors:  B G Durie; S E Salmon
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860

4.  Clinical features of common acute lymphoblastic leukemia antigen (CALLA)-positive myeloma: report of four cases.

Authors:  J Tamura; H Kurabayashi; M Sawamura; H Murakami; E Nogiwa; S Shinonome; S Miyawaki; K Kubota; S Sato; M Omine
Journal:  Blut       Date:  1989-05

5.  Multiple myeloma: significance of plasmablastic subtype in morphological classification.

Authors:  P R Greipp; N M Raymond; R A Kyle; W M O'Fallon
Journal:  Blood       Date:  1985-02       Impact factor: 22.113

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.